Xenon Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell XENE and other ETFs, options, and stocks.

About XENE

Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. 

CEO
Ian C. Mortimer
CEOIan C. Mortimer
Employees
327
Employees327
Headquarters
Burnaby, British Columbia
HeadquartersBurnaby, British Columbia
Founded
1996
Founded1996
Employees
327
Employees327

XENE Key Statistics

Market cap
2.41B
Market cap2.41B
Price-Earnings ratio
-9.48
Price-Earnings ratio-9.48
Dividend yield
—
Dividend yield—
Average volume
806.83K
Average volume806.83K
High today
$30.74
High today$30.74
Low today
$30.00
Low today$30.00
Open price
$30.29
Open price$30.29
Volume
748.89K
Volume748.89K
52 Week high
$46.00
52 Week high$46.00
52 Week low
$26.74
52 Week low$26.74

Analyst ratings

100%

of 19 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own XENE. This list is generated using Robinhood data, and it’s not a recommendation.
Pfizer
Plug Power
Ford Motor
Viking Therapeutics
NIO
Alibaba
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.